These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 814549)
21. Development of a new radiolabel (203Pb) and new chelating agents for labeling monoclonal antibodies for imaging. Srivastava SC; Mease RC; Meinken GE; Mausner LF; Steplewski Z Acta Radiol Suppl; 1990; 374():135-40. PubMed ID: 1966961 [TBL] [Abstract][Full Text] [Related]
22. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353 [TBL] [Abstract][Full Text] [Related]
23. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions. Lewis MR; Shively JE Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549 [TBL] [Abstract][Full Text] [Related]
24. New 111In labeling of IgG: 111In-oxine mediated chelation. Cole WC; Leblanc AD; Jhingran SG Int J Rad Appl Instrum B; 1988; 15(2):177-9. PubMed ID: 3130338 [TBL] [Abstract][Full Text] [Related]
25. Chelate radiochemistry: cleavable linkers lead to altered levels of radioactivity in the liver. Meares CF; McCall MJ; Deshpande SV; DeNardo SJ; Goodwin DA Int J Cancer Suppl; 1988; 2():99-102. PubMed ID: 3162452 [TBL] [Abstract][Full Text] [Related]
26. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates. Paxton RJ; Jakowatz JG; Beatty JD; Beatty BG; Vlahos WG; Williams LE; Clark BR; Shively JE Cancer Res; 1985 Nov; 45(11 Pt 2):5694-9. PubMed ID: 4053042 [TBL] [Abstract][Full Text] [Related]
27. [Basic studies on 111In chelate compounds for WBC labeling (author's transl)]. Suehiro M; Iio M Kaku Igaku; 1980 Mar; 17(2):133-8. PubMed ID: 7382179 [No Abstract] [Full Text] [Related]
28. Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments. Tsai SW; Li L; Williams LE; Anderson AL; Raubitschek AA; Shively JE Bioconjug Chem; 2001; 12(2):264-70. PubMed ID: 11312688 [TBL] [Abstract][Full Text] [Related]
29. Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. Deshpande SV; Denardo SJ; Meares CF; McCall MJ; Adams GP; Denardo GL Int J Rad Appl Instrum B; 1989; 16(6):587-97. PubMed ID: 2606714 [TBL] [Abstract][Full Text] [Related]
30. A comparative distribution study of 111In-labeled DTPA and TTHA monoclonal antibody conjugates in a choriocarcinoma xenograft model. Buckley RG; Barnett P; Searle F; Pedley R; Boden JA Eur J Nucl Med; 1986; 12(8):394-6. PubMed ID: 3098566 [TBL] [Abstract][Full Text] [Related]
31. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative. Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442 [TBL] [Abstract][Full Text] [Related]
32. Macrocyclic chelates of radiometals for diagnosis and therapy. Meares CF; Moi MK; Diril H; Kukis DL; McCall MJ; Deshpande SV; DeNardo SJ; Snook D; Epenetos AA Br J Cancer Suppl; 1990 Jul; 10():21-6. PubMed ID: 2383477 [TBL] [Abstract][Full Text] [Related]
33. Improved tumour localisation using indium-111 labelled antibodies. Fairweather DS; Bradwell AR; Dykes PW; Vaughan AT; Watson-James SF; Chandler S Br Med J (Clin Res Ed); 1983 Jul; 287(6386):167-70. PubMed ID: 6409238 [TBL] [Abstract][Full Text] [Related]
34. Terminal-modified polylysine-based chelating polymers: highly efficient coupling to antibody with minimal loss in immunoreactivity. Slinkin MA; Klibanov AL; Torchilin VP Bioconjug Chem; 1991; 2(5):342-8. PubMed ID: 1790174 [TBL] [Abstract][Full Text] [Related]
35. Comparative studies using 125I- and 111In-labeled monoclonal antibodies. Otsuka FL; Fleischman JB; Welch MJ Int J Rad Appl Instrum B; 1986; 13(4):325-34. PubMed ID: 3793486 [TBL] [Abstract][Full Text] [Related]
36. Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies. Roselli M; Schlom J; Gansow OA; Brechbiel MW; Mirzadeh S; Pippin CG; Milenic DE; Colcher D Int J Rad Appl Instrum B; 1991; 18(4):389-94. PubMed ID: 1864727 [TBL] [Abstract][Full Text] [Related]
37. Easy and efficient (111)indium labeling of long-term stored DTPA conjugated protein. Nalla A; Buch I; Hesse B Curr Radiopharm; 2011 Jan; 4(1):1-4. PubMed ID: 22191609 [TBL] [Abstract][Full Text] [Related]
38. Characterization of 111In and 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay. Nestor M; Andersson K; Lundqvist H J Mol Recognit; 2008; 21(3):179-83. PubMed ID: 18438972 [TBL] [Abstract][Full Text] [Related]
39. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution. Carrasquillo JA; White JD; Paik CH; Raubitschek A; Le N; Rotman M; Brechbiel MW; Gansow OA; Top LE; Perentesis P; Reynolds JC; Nelson DL; Waldmann TA J Nucl Med; 1999 Feb; 40(2):268-76. PubMed ID: 10025834 [TBL] [Abstract][Full Text] [Related]